Primary Record
Tosedostat
- In stock
- 5,503 g
- Purity
- 99.3 %
- CAS
- 238750-77-1
Compound Identifiers & Properties
- CAS
- 238750-77-1
- PubChem CID
- 15547703
- SMILES
- CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@@H](C1=CC=CC=C1)C(=O)OC2CCCC2
- Canonical SMILES
- CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO
Names & Synonyms
- Tosedostat
- 238750-77-1
- CHR 2797
- tosedostatum
- CHR-2797
- Tosedostat (CHR2797)
- Tosedostat [INN]
- UNII-KZK563J2UW
- CHR2797
- Tosedostat [USAN:INN]
- KZK563J2UW
- RefChem:898628
- Tosedostat (USAN/INN)
- TOSEDOSTAT [USAN]
- CHR-2797(Tosedostat)
- CHR-2797; Tosedostat
- CHR2797 - Tosedostat
- D0F2JS
- C21H30N2O6
- CHR-2797(Tosedostat)/
- Tosedostat (CHR2797)?
- TOSEDOSTAT [WHO-DD]
- MLS006011104
- DTXSID60178577
- orb1300889
- CHEMBL2103847
- SCHEMBL19236550
- CHEBI:95044
- CTK8F1311
- AOB6880
- DTXCID20101068
- MFCD13185162
- BCPP000283
- GLXC-05997
- HMS3414A15
- HMS3678A15
- Aminopeptidase inhibitor CHR-2797
- EX-A2628
- NJA75077
- ABP000293
- BDBM50277143
- NSC806020
- ZINC13914293
- BB-76163
- AKOS024457707
- ACN-057469
- AN-5385
- AT25061
- BCP9000524
- DB11781
- NSC-806020
- Tosedostat, CHR2797, CHR-2797
- NCGC00263175-01
- AC-35830
- AS-55983
- HY-14807
- SMR004676647
- RT-012009
- A4355
- CS-0003570
- NS00071015
- X7552
- Tosedostat, CHR2797, 238750-77-1
- A10208
- D10026
- Z-3145
- 750T771
- A857789
- BRD-K92241597-001-01-1
- BRD-K92241597-001-05-2
- BRD-K92241597-001-06-0
- BRD-K92241597-001-09-4
- Q27166812
- cyclopentyl (S)-2-((R)-2-((S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl)-4-methylpentanamido)-2-phenylacetate
- B0084-088218
- (S)-cyclopentyl 2-((R)-2-((S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl)-4-methylpentanamido)-2-phenylacetate
- Benzeneacetic acid, alpha-(((2R)-2-((1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl)-4-methyl-1-oxopentyl)amino)-, cyclopentyl ester, (alphaS)-
- cyclopentyl (2S)-2-[[(2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxo-ethyl]-4-methyl-pentanoyl]amino]-2-phenyl-acetate
- cyclopentyl (2S)-2-[[(2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl]amino]-2-phenylacetate
- ?-[[(2R)-2-[(1S)-1-Hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methyl-1-oxopentyl]amino]-benzeneacetic acid cyclopently ester
- 2-(2-(Hydroxy(hydroxycarbamoyl)methyl)-4-methylpentanoylamino)-2-phenylethanoic acid cyclopentyl ester
- BENZENEACETIC ACID, .ALPHA.-(((2R)-2-((1S)-1-HYDROXY-2-(HYDROXYAMINO)-2-OXOETHYL)-4- METHYL-1-OXOPENTY)LAMINO)-, CYCLOPENTYL ESTER, (.ALPHA.S)-
- Cyclopentyl (2S)-{(2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanamido}(phenyl)acetate
- CYCLOPENTYL (2S)-2-((2R)-2-((1S)-1-HYDROXY-2-(HYDROXYAMINO)-2-OXOETHYL)-4- METHYLPENTANAMIDO)-2-PHENYLACETATE
- CYCLOPENTYL (2S)-2-((2R)-2-((1S)-1-HYDROXY-2-(HYDROXYAMINO)-2-OXOETHYL)-4-METHYLPENTANAMIDO)-2-PHENYLACETATE
- cyclopentyl (2S)-2-((2R,3S)-3-hydroxy-3-(hydroxycarbamoyl)-2-(2-methylpropyl)propanamido)-2-phenylacetate
- cyclopentyl (2S)-2-[(2R,3S)-3-hydroxy-3-(hydroxycarbamoyl)-2-(2-methylpropyl)propanamido]-2-phenylacetate